These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17909374

  • 41. [Prevalence of diabetes in Switzerland: calculation based on drug sales].
    Jirovec M, Teuscher A, Bürgi U, Diem P.
    Schweiz Med Wochenschr; 1993 Nov 27; 123(47):2247-50. PubMed ID: 8272797
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A comparison of mixed-effects quantile stratification propensity adjustment strategies for longitudinal treatment effectiveness analyses of continuous outcomes.
    Leon AC, Hedeker D.
    Stat Med; 2007 Jun 15; 26(13):2650-65. PubMed ID: 17094068
    [Abstract] [Full Text] [Related]

  • 45. Drug utilization pattern and effectiveness analysis in diabetes mellitus at a tertiary care centre in eastern Nepal.
    Das P, Das BP, Rauniar GP, Roy RK, Sharma SK.
    Indian J Physiol Pharmacol; 2011 Jun 15; 55(3):272-80. PubMed ID: 22471235
    [Abstract] [Full Text] [Related]

  • 46. Outcomes of antipsychotic drug use in community-dwelling elders with dementia.
    Kolanowski A, Fick D, Waller JL, Ahern F.
    Arch Psychiatr Nurs; 2006 Oct 15; 20(5):217-25. PubMed ID: 17010825
    [Abstract] [Full Text] [Related]

  • 47. [Regional analysis of drug treatment prevalence and medication of diabetes mellitus in Germany].
    Willert T, Walker J, Schramm W.
    Dtsch Med Wochenschr; 2012 Nov 15; 137(46):2363-8. PubMed ID: 23132154
    [Abstract] [Full Text] [Related]

  • 48. A mixed-effects quintile-stratified propensity adjustment for effectiveness analyses of ordered categorical doses.
    Leon AC, Hedeker D.
    Stat Med; 2005 Feb 28; 24(4):647-58. PubMed ID: 15678413
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The use of the propensity score for estimating treatment effects: administrative versus clinical data.
    Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV.
    Stat Med; 2005 May 30; 24(10):1563-78. PubMed ID: 15706581
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data.
    Linden A, Adams JL.
    J Eval Clin Pract; 2010 Feb 30; 16(1):180-5. PubMed ID: 20367830
    [Abstract] [Full Text] [Related]

  • 59. Analysing duration of episodes of pharmacological care: an example of antidepressant use in Danish general practice.
    Gichangi A, Andersen M, Kragstrup J, Vach W.
    Pharmacoepidemiol Drug Saf; 2006 Mar 30; 15(3):167-77. PubMed ID: 16315340
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.